Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
16.49
-0.01 (-0.06%)
Feb 21, 2025, 4:00 PM EST - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $894.30 million as of February 21, 2025. Its market cap has decreased by -44.64% in one year.
Market Cap
894.30M
Enterprise Value
554.04M
1-Year Change
-44.64%
Ranking
Category
Stock Price
$16.49
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $894.30M, an increase of 40.44%. That is a compound annual growth rate of 8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 894.30M | -13.98% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |